Risk | Very High |
---|---|
Min SIP Amount | ₹500 |
Expense Ratio | 2.51% |
NAV | ₹105.21 (24 Feb 2021) |
---|---|
Fund Started | 27 May 1999 |
Fund Size | ₹617 Cr |
Name | Sector | Instrument | % Assets |
---|---|---|---|
Sun Pharmaceutical Inds. Ltd. | Healthcare | Equity | 10.4% |
Cipla Ltd. | Healthcare | Equity | 9.8% |
Aurobindo Pharma Ltd. | Healthcare | Equity | 9.2% |
Dr. Reddy's Laboratories Ltd. | Healthcare | Equity | 8.1% |
Divi's Laboratories Ltd. | Healthcare | Equity | 5.9% |
Eris Lifesciences Ltd | Healthcare | Equity | 5.7% |
Cadila Healthcare Ltd. | Healthcare | Equity | 4.7% |
Narayana Hrudayalaya Ltd. | Healthcare | Equity | 4.2% |
Ajanta Pharma Ltd. | Healthcare | Equity | 3.9% |
Fortis Healthcare (India) Ltd | Healthcare | Equity | 3.4% |
UTI Healthcare Fund Regular Plan Dividend is a Equity Mutual Fund Scheme launched by UTI Mutual Fund. This scheme was made available to investors on 27 May 1999. V Srivatsa, Ritesh Rathod is the Current Fund Manager of UTI Healthcare Fund Regular Plan Dividend fund.The fund currently has an Asset Under Management(AUM) of ₹617 Cr and the Latest NAV as of 24 Feb 2021 is ₹105.21.
The UTI Healthcare Fund Regular Plan Dividend is rated Very High risk. Minimum SIP Investment is set to 500. Minimum Lumpsum Investment is 5000. Exit load of 1% if redeemed less than 1 year
The scheme seeks to generate long term capital appreciation by investing predominantly in equity and equity related securities of companies/institutions engaged in the Healthcare Services Sector.
Returns are taxed at 15%, if you redeem before one year. After 1 year, you are required to pay LTCG tax of 10% on returns of Rs 1 lakh+ in a financial year.